Subjects with confirmed diagnosis of human immunodeficiency virus HIV infection are excluded at the investigator 's discretion if he/she feels that 1 a potential drug interaction between ZD6474 Vandetanib and any of the patient 's anti-HIV medications could influence the efficacy of the anti-HIV medication or 2 it may place the patient at risk due to the pharmacologic activity of ZD6474 Vandetanib 